Exosens (FR:EXENS)
:EXENS
Want to see FR:EXENS full AI Analyst Report?
Top Page
Exosens
(EXENS)
Select Model
Select Model
Rating:62Neutral
Price Target:
€72.00
▲(10.01% Upside)
Action:Reiterated
Date:03/24/26
The score is driven primarily by improving financial performance (growth, profitability, and deleveraging), tempered by notable 2025 margin compression and weaker cash conversion. Technicals are broadly supportive longer-term but neutral near-term, while the high P/E meaningfully weighs on the overall rating.
Positive Factors
Consistent revenue and strong EBITDA margins
Exosens has delivered steady revenue growth alongside robust operating profitability (EBITDA ~29–30% in 2024–2025). That level of recurring margin supports durable cash generation, funds R&D and capex, and underpins competitive investment and deleveraging over the medium term.
Negative Factors
Sharp gross-margin compression
A dramatic drop in gross margin is a structural red flag: it suggests adverse mix shifts, pricing pressure, or rising input costs that materially weaken core economics. If sustained, this erodes operating leverage and requires strategic responses (pricing, cost control, product mix) to restore profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent revenue and strong EBITDA margins
Exosens has delivered steady revenue growth alongside robust operating profitability (EBITDA ~29–30% in 2024–2025). That level of recurring margin supports durable cash generation, funds R&D and capex, and underpins competitive investment and deleveraging over the medium term.
Read all positive factors
Exosens (EXENS) vs. iShares MSCI France ETF (EWQ)
Market Cap
€3.03B
Dividend Yield0.21%
Average Volume (3M)187.72K
Price to Earnings (P/E)123.5
Beta (1Y)0.60
Revenue Growth18.81%
EPS Growth157.23%
CountryFR
Employees1,214
SectorTechnology
Sector Strength88
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)0.84
Shares Outstanding50,936,750
10 Day Avg. Volume184,892
30 Day Avg. Volume187,724
Financial Highlights & Ratios
PEG Ratio1.44
Price to Book (P/B)5.54
Price to Sales (P/S)5.27
P/FCF Ratio50.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€66.17Price Target Upside1.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)1.88
Revenue Forecast (FY)€536.42M
Exosens Business Overview & Revenue Model
Company Description
Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. Its core expertise lies in amplification, detection, and imaging solutions, catering to markets across France, the rest of Europe...
How the Company Makes Money
null...
Exosens Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
66
Positive
Cash Flow
63
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 468.20M | 394.10M | 318.80M | 200.75M | 166.17M |
| Gross Profit | 102.20M | 225.60M | 176.81M | 113.95M | 100.03M |
| EBITDA | 142.10M | 115.20M | 83.91M | 51.25M | -101.18M |
| Net Income | 42.70M | 30.70M | 17.14M | 11.21M | -148.97M |
Balance Sheet | |||||
| Total Assets | 878.90M | 817.00M | 656.41M | 529.25M | 460.52M |
| Cash, Cash Equivalents and Short-Term Investments | 101.90M | 150.20M | 15.53M | 29.00M | 15.93M |
| Total Debt | 280.00M | 261.28M | 311.77M | 255.28M | 208.11M |
| Total Liabilities | 433.30M | 404.40M | 452.35M | 346.20M | 288.41M |
| Stockholders Equity | 445.70M | 412.60M | 204.06M | 183.05M | 172.11M |
Cash Flow | |||||
| Free Cash Flow | 48.50M | 96.20M | 19.53M | 25.69M | 23.07M |
| Operating Cash Flow | 98.60M | 96.20M | 50.46M | 47.48M | 42.66M |
| Investing Cash Flow | -121.20M | -72.70M | -99.64M | -55.48M | -21.26M |
| Financing Cash Flow | -16.40M | 76.30M | 35.49M | 20.26M | -36.83M |
Exosens Technical Analysis
Negative
65.45
Price Trends
62.51
Negative
61.57
Negative
54.04
Positive
Market Momentum
-0.80
Positive
43.63
Neutral
32.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:EXENS, the sentiment is Negative. The current price of 65.45 is above the 20-day moving average (MA) of 62.70, above the 50-day MA of 62.51, and above the 200-day MA of 54.04, indicating a neutral trend. The MACD of -0.80 indicates Positive momentum. The RSI at 43.63 is Neutral, neither overbought nor oversold. The STOCH value of 32.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:EXENS.
Exosens Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €1.25B | 25.29 | ― | 1.37% | 7.95% | 16.68% | |
62 Neutral | €3.03B | 123.54 | ― | 0.21% | 18.81% | 157.23% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | €91.07M | -2.31 | -4.96% | 5.91% | -29.90% | -17.13% | |
53 Neutral | €56.44M | -75.15 | ― | 2.17% | 10.23% | -110.11% |
* Technology Sector Average
FR:EXENS
Exosens
60.10
15.51
34.77%
FR:LACR
Lacroix Group SA
19.55
11.81
152.58%
FR:ALNSE
NSE SA
50.60
6.75
15.40%
FR:ALGTR
Groupe Tera SA
4.46
-0.79
-15.05%
FR:ALICA
ICAPE HOLDING
7.04
-0.30
-4.09%
FR:PLNW
Planisware Societe anonyme
17.80
-6.74
-27.47%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.